Status:
UNKNOWN
The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac Surgery
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Dexmedetomidine
Delirium
Eligibility:
All Genders
60-100 years
Phase:
NA
Brief Summary
The investigators aim to evaluate the roles of α7nAchR in the mechanisms of dexmedetomidine in improving delirium after cardiac surgery. The results of this study would lay the foundation for revealin...
Eligibility Criteria
Inclusion
- ICU patients underwent cardiac surgery
- age ≥ 60 years
Exclusion
- Preoperative cognitive decline, mental illness,
- preoperative long-term use of hormone patients,
- preoperative alcohol dependence,
- patients with alcohol withdrawal symptoms
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04127500
Start Date
August 1 2019
End Date
August 31 2020
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital
Nanjing, Jiangsu, China, 210006